covexit.com - covid-19 news & policy analysis

This interview with Jessica Rose, PhD, covers the question of vaccine safety, as it can be evaluated from actual real world data collected into the so called "VAERS" system. Sub-titles are available in Spanish & Portuguese, yet refer only to the spoken English version in case you have doubt about the meaning of what is said. The interview covers the question of the nature and magnitude of adverse effects, as compared to previous vaccination programs; the issue of under-reporting, which is considerable; the question of causality between an adverse event and an injection and the extent to which causality can be established, using the Bradford Hill Criteria. There is also a discussion of effectiveness, with Dr Rose answering the somewhat rhetorical question whether these injections are as effective as they are safe. Dr Rose then answers some questions from the audience. The interview relies on a few slides, which you can find at: https://covexit.com/wp-content/uploads/2021/09/slides_Dr_Rose_talk.pdf Find the podcast version at http://covexit.com/podcast

Note: Subtitles are now available in English, French & Spanish! In this interview with internationally renowned Dr. Shankara Chetty from South Africa, we discuss the Omicron variant, which is taking the world as a storm. Is this variant to be feared, or could it actually be a positive development in this pandemic, as mostly inducing mild disease, yet conferring post-covid natural immunity? Is the typical governmental response, to administer more booster shots and to implement new restrictions, appropriate or ill-conceived? These are among the timely and critically important aspects we discuss. Dr. Chetty is a Family General Medical Practitioner in South-Africa, with considerable experience with the outpatient treatment of COVID-19, having treated so far nearly 8,000 patients, in his outpatient practice, without any of them requiring hospitalization or even oxygen. Dr. Chetty holds a degree in medicine and surgery and also has advanced education in genetics, advanced biology, biochemistry and microbiology.

This interview of Dr. Ira Bernstein, from Toronto, Canada, is about the recent International Covid Summit held in Rome, which gathered medical doctors from all over the world to discuss and promote early outpatient treatment. The San Jan (Puerto Rico) Declaration, presented at the summit is also discussed, so is the recent COVID-19 Declaration by the Canadian Covid Care Alliance (CCCA). You can find the text of the Rome Declaration at: http://doctorsandscientistsdeclaration.org/ and the text of the CCCA Declaration at: https://covexit.com/covid-19-declaration-issued-by-the-canadian-covid-care-alliance/

These are the remarks of Dr. Shankara Chetty from South Africa, very well known for his 8th Day Therapy for COVID-19. Dr. Chetty comments on how he treats for the Delta variant, on an ambulatory / outpatient basis, both for vaccinated and non-vaccinated patients.

This is a presentation by Dr. Ryan Cole, part of a webinar by covexit.com about the early treatment of the delta variant. Dr. Cole goes in depth about what is the Delta variant, what are its particularities and how to best treat it, based on current available knowledge.

Dr. Pierre Kory offers remarks about the evolution of treatments in face of the rise of the delta variant, and discusses the upcoming revisions in the FLCCC protocols, particularly in the MATH+ hospital-level treatment protocol. Dr. Kory also comments on particularly important aspects, such as the unfortunate lack of continuity in the treatments if patients get admitted in hospital.

Dr. Richard Urso is one of the most prominent frontline doctors in the US, having been at the forefront of the battle for the early treatment of COVID-19 since early 2020. His remarks are those not only of a frontine doctor but also an expert in the repurposing of drugs.

This is Part 1 of my interview with Dr. Mark McDonald, Medical Doctor and Psychiatrist from California. We discuss the imposition of unnecessary and potentially harmful vaccines to children, the passivity of the health authorities regarding the substantial safety issues associated with the injections, the mandates, the passports and other coercive measures; the implications for families, which can be devastating; and the evolution of our societies towards authoritarianism. In Part 2, we will discuss education and other crucial matters for the future of our children and of society.

In this second part of the interview, 
Mark McDonald, MD & Psychiatrist, 
comments on key current issues, including asymptomatic testing; the false sense of safety given by the vaccines; virtue signalling; critical thinking; home schooling; university education; last year’s American Frontline Doctors’ event in Washington, DC; the reactions to Dr. Stella Emmanuel’s speech; medical freedom & more.

In this first part of our interview, 
Dr. John Littell, MD, from Florida, tells us about his experience with treating COVID-19, about his perspectives regarding vaccination, especially of children, and about the trends with COVID-19 policy, particularly in Florida. The second part of the interview focuses on the recently held Florida COVID Summit.

Now that you have watched the first four parts of our webinar on the treatment, especially the early treatment, of the Delta variant of COVID-19, you are invited to watch this discussion among the four distinguished doctors, with some questions from the audience.

In this second part of our interview, 
Dr. John Littell tells us how the Florida COVID Summit came to life. He shares with us what were, from his perspective, highlights of the event, which attracted nearly 1,000 delegates, making it the largest C19 conference ever in the world. Dr. Littell also further comments on his hopes for concrete policy changes in Florida.

In this interview with internationally renowned cardiologist Dr. Joel Kahn, we discuss early outpatient treatment for COVID-19, adverse events such as heart attacks, pericarditis and myocarditis; risks for children, adolescents and young adults; and risks associated with altitude while flying. Dr. Khan, who is an expert in plant-based nutrition and longevity, also shares his top 3 plants to incorporate in our meals.

This is the first part of our interview with the esteemed Professor Thomas Borody, which covers the following aspects: What is the recommended ivermectin-based tri-therapy How is this early therapy administered to old and younger people alike Examples of elderly people “turning the corner” after being treated The increasing adoption of the tri-therapy in Australia Professor Thomas Borody is a world renowned medical doctor from Australia with over 40 years experience in clinical research and practice, including at the St Vincent Hospital in Sydney and at the Mayo clinic in the US. Some of his most ground breaking contributions in medical science include the development of a tritherapy for peptic ulcers, the development of faecal microbiota transplants for colitis and other diseases, and recently, a therapy for Crohn disease. In 1984 he established the Centre for Digestive Diseases in Sydney. He oversaw its growth into an active clinical research institute with 65 employees. Professor Borody has published numerous articles and is a reviewer for leading international medical journals. With the pandemic, Professor Borody took a particular interest in researching a therapy for COVID-19, and this is what this interview is all about. ============== Here is the transcript of the first part of the interview. I’d like to ask you maybe to start by presenting in a nutshell the therapy you recommend for covid19. Thank you and that’s a big introduction and i thought i should start by introducing the medical aspects of my thinking in that my background is in gastroenterology and infectious diseases. So i spent a year training in infectious diseases in the tropics and Solomon Islands as well, but my main purpose is in fact in reusing or repurposing combined medications. So that’s where we ended up with the helicobacter work and the three products that have been FDA approved helidac pilera and topelia most recently the best examples of those is the therapy that we talk about, which is more than just Ivermectin but it’s Ivermectin with doxycycline and zinc. Can you explain how do you treat patients with this with these three medications? Well we treat them for 10 days using an appropriate dose of ivermectin, doxycycline daily and zinc daily. They all actually have activity against the intracellular multiplication of the virus and from published data you can read that most of the results have been close to 100 percent cure there was one that used the lower level and got 92 percent cure but it’s just hard to believe how simple it is to cure coronavirus. As you know this is a contentious assertion you are making because officially there is no cure for covid19. What is your definition of a cure for a disease? Right, well officially there was no cure for ulcer disease. Let’s never forget that those who don’t know will make such statements but cure is when a patient regains all the symptoms if they had any and that they are swapped negative on two different occasions. Now we don’t treat people who are almost dead because that you missed the boat we treat the asymptomatic and the symptomatic and that way they do not go to hospital so there will be no symptoms in the end and no ventilators and no mortality. So your focus today is outpatients? Exactly that needs to be understood. Outpatients treatment. You haven’t missed the boat. If you treat too late, yes there is a reduction in death rate, as published from Florida: about 48%, which is much better than any other known drug. But i’m focusing on treating patients before they develop symptoms, hopefully when the viral load is low. So it’s a it’s a similar approach to Dr Zelenko and his tai-therapy? Exactly and I think he just hasn’t been listened to. Are there contra indications to the therapy you are recommending? Well the drugs are very well tolerated. From published literature, there are no category categorical contraindications. But this is an area where the doctor-patient relationship comes in and if for some reason there is an allergy to the doxycycline, well then the answer is obvious. Concretely, I understand that you have an initiative to treat patients in elderly homes. Can you tell us about it? There is no age limit in treating, and in fact, it has been used without any major side effects in pregnant women and children – even if we don’t recommend they should. But it works fairly well in elderly people. But remember, elderly people also have elderly immune systems, so it takes much longer for the swabs to become negative. But you can treat at virtually at any age and we have examples of people who just turn the corner in the sort of 60 to 70s three to four days but we’ve gone up as far as you know in the 90s and and people improve. So the attending GP treats the patient and it works in the elderly as well as in any other group. Can you provide maybe some very concrete examples of people who were saved by the therapy? Well, you’ll never know those were saved because you never compared with not treating them. But essentially, for elderly people, I’m just thinking of one lady who had not seen her family for six months, being in a nursing facility in the red zone as they call it. She had a marked cough, loss of appetite, she had some muscle aches, malaise and by day three to four she had marked improvement, regained her appetite, her cough improved. The cough took about 10 days to completely disappear. Others are currently on treatment in those areas and two others come to mind in our US trial caught myalgia, malaise and fever. These were patients in a placebo group, in a different trial, and so we have a rescue therapy and the ivermectin based rescue over the next two days got them to experience rapid improvement, which is a fascinating phenomenon to watch how quickly patients turn around, I mean some of them in just hours, and they call back our counterpart in the US and say look I’m so much better. I have never seen helicobacter treatment do that, so I’m just trying to say that this is such a unique therapy I’ve never come across anything like this in treating infectious diseases. I mean Crohn’s takes six weeks to change symptoms. So how in practice does it work in an elderly home? Are the families asking for the treatment to take place? Or is the GP of the elderly home taking charge of offering the treatment when it’s needed? Well you may have noticed that this has become much better known in Australia through the media and both families and general practitioners are starting to treat more people. What about young people people, those not above say 60 and who don’t have co-morbidities? Are you treating them too? If someone’s positive on a swab, we treat them, but if they have to live close to someone who is being treated, I would recommend some lower dose preventative treatment. And that would be safe because you really need about three days and you’re no longer infective. What kind of research mechanism are you implementing to monitor and to report on your results? Well we are treating everybody mainly because we cannot make a decision between who shall live and who shall die. We’re using historical controls specifically in the aged care facilities. If it was something like a disease like hypertension, we would have a placebo arm, but you cannot really have that in a situation where there is no alternative treatment. Regarding the information from treating various patients, are you planning to gather it and analyze it and publish it? Exactly, we will be comparing those that straight observational data with retrospective historical data from the same homes. It will not be the ideal situation, but we are forced by this type of condition to have to go this pathway. If anyone suggests a randomized controlled trial, it tells me they don’t know what they’re talking about.

We are reposting here our March 2021 landmark interview of Dr. Peter McCullough and Dr. Geert Vanden Bossche, to provide context to a March 2022 Update by the two same experts.

This is a far ranging interview with Steve Kirsch, the founder of the COVID-19 Early Treatment Fund. The interview covers, inter alia, early outpatient treatment, vaccination, governmental responses to the pandemic, the role of tech companies and freedom of expression. Steve Kirsch is a serial entrepreneur, the inventor of the optical mouse and a philanthropist.

Dr Andrea Stramezzi has treated early, on an outpatient basis for Covid-19 since the beginning of the pandemic in Italy, in February 2020, and is still doing so today, despite all the hurdles, despite all the nay sayers. In this interview, Dr Stramezzi talks about his experience and his perspectives about the treatment of Covid-19, about his plans for a telemedicine service and also about the upcoming International Covid Summit to be held in Rome mid September. You are invited to visit Dr Stramezzi’s website http://covidhealer.org and you may consider making a donation for the important projects carried out by his non-profit organization. Also, visit our website http://covexit.com to read our articles and watch our webinars and interviews.

California-based & Harvard graduate Dr George Fareed provides an update about the outpatient treatment of COVID-19, for newly infected and for long covid patients. He explains the early treatment protocols he has successfully implemented jointly with Dr Brian Tyson on thousands of patients. Dr Fareed’s invaluable perspectives rely on over 50 years of experience both as a clinical researcher and as a family medicine specialist. This interview is presented strictly for the purpose of information exchange only, not for therapeutic advice or for self-medication. For therapeutic advice, please contact your health care provider or medical doctor. We experienced a technical issue with the audio recording that we are unable to resolve. Given the importance of the interview, we are still presenting it, despite this issue.

Dr. Byram Bridle is a world renowned immunologist and vaccine expert. He is particularly critical regarding the current Covid 19 injections, which he considers to be high risk, especially for the children. Clip from footage by Druthers News & Information

With Dr Chetty (South Africa), Dr Bernstein (Canada) and Professor McCullough (USA). Of particular significance is the discussion of Dr Chetty's "8th Day Therapy" for COVID-19, discussed in more detail in this article: https://covexit.com/the-8th-day-therapy-for-covid-19/

These are the initial remarks by Dr. Henry Ealy, made in the context of his interview, on September 4, about COVID-19 prevention. Dr Henry Ealy is a Naturopathic Doctor and Holistic Nutritionist located in Oregon, USA. You can listen to the full interview at https://covexit.com/podcast as well as on the main podcast platforms such as Apple and Spotify.

This is a far reaching interview with Nick Hudson, who is the leader of PANDA, which stands for Pandemics Data & Analytics. The interview covers a range of fundamental aspects of the pandemic, including lockdowns; masks; testing; early outpatient treatment & vaccines; the Great Barrington Declaration; information and censorship; trends towards technocratic centralization & responses such as populism to counter them; the live data available at pandata.org and the role of the organization in the future. The chairman of PANDA, Nick Hudson is an actuary with broad international experience in finance, who has settled into a career as a private equity investor. He is a man of wide-ranging interests—an avid reader of canonical literature, a classical music aficionado, and an enthusiastic amateur ornithologist. He has been invited to speak on various topics including epistemology, corporate governance, investment management, and more recently, the pandemic. Visit PANADA’S website at https://www.pandata.org/ For other interviews & for articles: http://covexit.com/

These are introductory remarks to the September 4 interview with Dr. Henry Ealy about the Prevention of COVID-19. The interview is available in audio only, at https://covexit.com/podcast and on the leading podcast platforms. Also don't miss our previous interview with Dr Ealy, which focused on Vitamin D.

We are very honored to present this interview of Dr Vladimir Zelenko, the father of outpatient treatment for COVID-19 in North America. Dr Zelenko shares his own experience with COVID-19 as a patient, as he is recovering from a severe form of the disease. He also talks about his cancer and how he was able to go through this dramatic episode of his life. Then, he presents his perspectives about outpatient treatment as practiced today and the evolution of the pandemic, among other topics. Watch the interview or listen to it on our Spotify Podcast.

With over 20,000 consultations, MyFreeDoctor.com has become a leading telemedicine service for the early treatment of COVID-19 in the USA. Learn about how this initiative came to birth, how it evolved, and what are the plans for Dr Marble has for further expanding the initiative, both nationally and internationally.